Sector: Pharmaceuticals & Biotechnology

Small Cap

Bafna Pharma Share Price

BAFNAPH

₹254.55

12.10(4.99%)

24th Aug 2026 | 2:39 PM

NSE : BAFNAPH

Open Free Demat Account

Bafna Pharma Performance

Price Movement

₹254.55

₹250.00

₹254.55

↘ Today's Low↗ Today's High

1 Year Performance

₹254.55

₹91.20

₹290.70

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹254.55

Low₹250.00

Open at₹253.90

Prev Close₹242.45

Volumes10.13 K

Avg Price₹254.38

Lower Circuit₹230.35

Upper Circuit₹254.55

Historical Performance

3M High₹290.70

3M Low₹125.00

1 Yr High₹290.70

1 Yr Low₹91.20

3 Yr High₹290.70

3 Yr Low₹69.00

5 Yr High₹290.70

5 Yr Low₹69.00

Summary

As of 25-08-2026 01:59, Bafna Pharmaceuticals Ltd. share price today is ₹0, with a change of ₹-242.45 (-100.00%) from the previous close of ₹242.45. The stock opened at ₹253.9 and traded between ₹250 and ₹254.55, with a total traded volume of 10132 shares. The company has a market capitalization of ₹573.5 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹290.7 and ₹91.2, respectively.

Bafna Pharmaceuticals Ltd. valuation metrics include a P/E ratio of 73.7, and book value of ₹6.00. Profitability indicators show ROE of 11.54%. Bafna Pharmaceuticals Ltd. has reported revenue of ₹142.58 Cr and net profit of ₹7.79 Cr.

Bafna Pharmaceuticals Ltd. technical indicators include Day RSI at 46.42, Day MFI at 93.55, Day ADX at 36.73. Additional indicators include Commodity Channel Index (CCI) at -109.2 and Williams %R at -83.55. Momentum indicators show Day MACD at 5.08, Day MACD Signal Line at 11.56, DayATR at 5.94. Rate of Change indicators for Bafna Pharmaceuticals Ltd. include ROC125 at 105.21 and ROC21 at -0.23.

Exponential moving averages include EMA5 at ₹245.7, EMA10 at ₹251.9, EMA12 at ₹253, EMA20 at ₹251.7, EMA26 at ₹247.9, EMA50 at ₹228, EMA100 at ₹197.6, EMA200 at ₹167.8. Simple moving averages include SMA5 at ₹244.6, SMA10 at ₹256.5, SMA20 at ₹261, SMA30 at ₹249.6, SMA50 at ₹225.3, SMA100 at ₹181.2, SMA150 at ₹159.3, SMA200 at ₹158.5.

Support levels for Bafna Pharma are placed at First Support ₹236.12, Second Support ₹229.78, Third Support ₹226.62. Resistance levels are seen at First Resistance ₹245.62, Second Resistance ₹248.78, Third Resistance ₹255.12. Bafna Pharmaceuticals Ltd. shareholding pattern shows promoter holding at 75%, FII holding at 9.34%, DII holding at 0%, public holding at 15.66%.

Bafna Pharma Fundamentals

Market Cap

Above industry Median

573.50 Cr.

PE Ratio (TTM)

High in industry

73.70

Dividend Yield

Net Profit TTM

6% decr over last year

7.79

Net Profit Growth

6% decr over last year

7.79

PEG Ratio

Negative PEG TTM

-12.70

ROE

136.0% incr over last year

11.54

Operating Revenue TTM

142.58

Operating Revenue Growth

3% decr over last year

Book Value

High in industry

MFI

MFI strongly Overbought

93.55

RSI

RSI is mid-range

46.42

EPS (TTM)

-15.52

Debt to Equity

-0.71

Face Value

Operating Profit Margin Qtr.

2.86

Operating Profit Qtr.

4.24

Net Profit Qtr.

0.32

Operating Revenue Qtr.

13.13

PB Ratio

Bafna Pharma Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025
Total Revenue	26.58	42.24	38.29	35.47	34.62
Operating Expense	25.70	38.69	35.24	31.19	29.56
Operating Profit	0.88	3.55	3.05	4.28	5.07
Depreciation	1.78	1.66	1.57	1.47	1.37
Interest	0.94	1.03	0.86	0.86	0.91
Tax	0	-0.13	0	0	0
Net Profit	0.08	2.75	1.84	3.12	3.39

Bafna Pharma Technicals

Bafna Pharmaceuticals Ltd. EMA & SMA

₹254.55

16.85 (7.09%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹245.7

Day EMA10 ₹251.9

Day EMA12 ₹253

Day EMA20 ₹251.7

Day EMA26 ₹247.9

Day EMA50 ₹228

Day EMA100 ₹197.6

Day EMA200 ₹167.8

Bafna Pharma Support and Resistance

Resistance

First Resistance₹245.62

Second Resistance₹248.78

Third Resistance₹255.12

Support

First Support₹236.12

Second Support₹229.78

Third Support₹226.62

Technical Indicators

Day RSI46.42

Day MFI93.55

Day ADX36.73

Day Commodity Channel Index-109.20

William-83.55

Day MACD5.08

Day MACD Signal Line11.56

Day ATR5.94

Day ROC125105.21

Day ROC21-0.23

Bafna Pharma Shareholding Pattern

Held By	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Promoter	75	75	75	75	75	75
FII	8.5	9.3	9.3	9.3	9.3	9.3
DII	0	0	0	0	0	0
Public	16.5	15.7	15.7	15.7	15.7	15.7

Bafna Pharma Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	27.22 K	27.22 K	100.00%
Week	8.98 K	8.98 K	100.00%
1 Month	43.55 K	43.55 K	100.00%
6 Month	18.37 K	20.19 K	90.97%

Bafna Pharma SWOT Analysis

Strengths19

Weakness9

Opportunity0

Threats0

Benjamin Graham Value Screen

30 Day SMA crossing over 200 Day SMA, and current price greater than open

Expensive Stars (DVM)

Consistent high performing stocks over Five Years

Relative Outperformance versus Industry over 1 Month

Relative Outperformance versus Industry over 1 Year

Growth Stars: Strongest Annual EPS Performers

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Month

Overbought by Money Flow Index (MFI)

Companies with Low Debt

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

Highest Recovery from 52 Week Low

Top Gainers

Volume Shockers

Stocks Outperforming their Industry Price Change in the Quarter

Bafna Pharma Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
19 Sep, 2013	0.6	FINAL		Equity Share

Bafna Pharma Stock Comparison

Financials	Sai Parenterals Ltd.	Vivimed Labs Ltd.	Amanta Healthcare Ltd.	Anlon Healthcare Ltd.	Amrutanjan Health Care Ltd.	Valiant Laboratories Ltd.
Price (₹)	₹526.25	₹6.55	₹205.20	₹15.46	₹518.70	₹100.52
% Change	-2.70%	4.97%	4.81%	8.26%	-3.29%	4.99%
Revenue TTM (₹ Cr)	₹526.28	₹69.99	₹291.17	₹226.23	₹511.48	₹305.93
Net Profit TTM (₹ Cr)	₹20.77	₹-176.47	₹14.68	₹31.63	₹53.97	₹16.01
PE TTM	115.10	-0.30	51.80	2.40	28.70	32.50
1 Year Return	37.97	524	55.39	56.92	-23.59	8.81
ROCE	3.56	-56.37	-	17.36	23.87	0.77

Similar Stocks

SIGACHI

Sigachi Industries Ltd.

₹ 30.45

+1.33%

WINDLAS

Windlas Biotech Ltd.

₹ 988.00

-0.56%

VINEETLAB

Vineet Laboratories Ltd.

₹ 37.00

-2.14%

SOLARA

Solara Active Pharma Sciences Ltd.

₹ 628.00

+1.80%

ZIMLAB

Zim Laboratories Ltd.

₹ 124.16

-0.70%

MEDICO

Medico Remedies Ltd.

₹ 42.09

-1.31%

DCAL

Dishman Carbogen Amcis Ltd.

₹ 173.00

-0.31%

LASA

Lasa Supergenerics Ltd.

₹ 7.33

+1.81%

HALEOSLABS

Haleos Labs Ltd.

₹ 1500.00

+2.39%

ADVENZYMES

Advanced Enzyme Technologies Ltd.

₹ 302.20

+0.73%

BAJAJHCARE

Bajaj Healthcare Ltd.

₹ 322.00

+0.00%

ORTINGLOBE

Ortin Global Ltd.

₹ 15.26

-3.96%

BROOKS

Brooks Laboratories Ltd.

₹ 61.70

+2.83%

RPGLIFE

RPG Life Sciences Ltd.

₹ 2638.00

+0.05%

ALPA

Alpa Laboratories Ltd.

₹ 61.20

-2.47%

SMSPHARMA

SMS Pharmaceuticals Ltd.

₹ 354.00

-0.73%

NECLIFE

Nectar Lifesciences Ltd.

₹ 10.80

+3.15%

MANGALAM

Mangalam Drugs and Organics Ltd.

₹ 30.44

+9.97%

INDOCO

Indoco Remedies Ltd.

₹ 220.00

-2.78%

INDSWFTLAB

Ind-Swift Laboratories Ltd.

₹ 325.35

-1.29%

LINCOLN

Lincoln Pharmaceuticals Ltd.

₹ 612.00

-0.33%

PANACEABIO

Panacea Biotec Ltd.

₹ 406.50

-1.12%

MEDICAMEQ

Medicamen Biotech Ltd.

₹ 234.00

-4.31%

THEMISMED

Themis Medicare Ltd.

₹ 120.50

+13.53%

FAQ's on BAFNAPH

What is the current share price of Bafna Pharmaceuticals Ltd.?

As of 6 June 2025 at 10:01 AM, the share price for Bafna Pharmaceuticals Ltd. is ₹ 254.55 on the NSE and ₹ 259.35 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

What is the Market Capitalization of Bafna Pharmaceuticals Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Bafna Pharmaceuticals Ltd. is approximately ₹ 573.5 Cr.

What are the PE and PB ratios for Bafna Pharmaceuticals Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Bafna Pharmaceuticals Ltd. is 73.7, and the Price-to-Book (PB) ratio is 6.

What is the 52-Week High and Low for Bafna Pharmaceuticals Ltd.?

Over the past 52 weeks, the highest price reached by Bafna Pharmaceuticals Ltd. shares was ₹ 290.7, and the lowest price was ₹ 91.2.

Who are the major shareholders of Bafna Pharmaceuticals Ltd.?

Significant shareholdings in Bafna Pharmaceuticals Ltd. typically include entities such as:

Promoter
Public
FII
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Bafna Pharmaceuticals Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Bafna Pharmaceuticals Ltd. is often compared with other major players such as Bio Medica Laboratories, Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda and Rekvina Laboratories for analysis and benchmarking.

What is the latest dividend information for Bafna Pharmaceuticals Ltd.?

Bafna Pharmaceuticals Ltd. last declared a FINAL dividend of ₹ 0.6 per share for the financial period ending 2013. The record date was set as 2013-09-19, and the payment was/is scheduled around 2013-09-19. For the most current dividend announcements, refer to official company filings.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy